Navigation Links
CHEENY KUM: The Mobile - Online Way to Monitor Diabetes
Date:10/29/2009

MUMBAI, India, October 29 /PRNewswire/ -- The launch of latest diabetes healthcare web-portal http://www.cheenykum.com allows an individual to access sugar levels and diabetic statistics and share this information with their doctor, family and friends, hence a means to track dangerous trends and a relevant lifestyle & diabetic health management tool.

The initiative has been undertaken as India, with over 50 million diabetics is currently the Diabetes Capital of the World and can reach alarming figures by 2025. An early onset of diabetes has maximum impact on children, hence affecting the future health of our nation. A hereditary disease like diabetes, if unchecked, can lead to serious complications such as kidney failure, lower limb amputations, blindness, heart disease, strokes and nerve damage.

'Cheeny Kum' (which literally means 'less sugar'),is a real-time monitoring and comprehensive management program for diabetes .The program enables you to easily input your daily blood sugar levels with a mobile phone, email or web-browser. You then receive advice for diet and physical activity from your personal diabetes educator via sms or voice calls. Sometimes, if your sugar levels are dangerously high or low, the program alerts your doctor, thus facilitating an informed decision for proper medical management.

"If your blood sugar is high today, it needs to be controlled today", said Dr. Vyankatesh Shivane (Diabetologist), at a patient education program conducted in South Mumbai recently. With Cheeny Kum, whether at home, on the road or in the office, your sugar, medications, diet & physical activity are managed in real-time, which is the key to managing diabetes and preventing its life-altering complications.

If you're a diabetic or at high risk of diabetes, you can opt for a personalized Cheeny Kum Plan, offered to you at an affordable pre-fixed cost. Moreover, with Cheeny Kum's doorstep services, there's no need to go anywhere for glucometers and test strips, medications and lab tests.

India being a low cost provider, offers the best resource centers for diabetes research studies. "Cheeny Kum has proven to be a quick and effective tool for patient pooling and study management for diabetes clinical trials", says Dr. Viral Shah, Director of Mumbai-based Spectrum Clinical Research, after contracting Cheeny Kum's organized care services for a global insulin study.

"Our goal is to provide all stakeholders, i.e. patients, doctors, authorized healthcare professionals, caregivers and even patients' family with a simple & easy-to-use solution that maximizes their benefits", comments, Dr. Ankit Khambhati, the program Director.

    Media Contacts

    Dr. Ankit Khambati
    M: +91-9820661176
    E: ankit@exemplacare.com

SOURCE Dianthus Consultancy


'/>"/>
SOURCE Dianthus Consultancy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bariatric Advantage Launches First of Its Kind Mobile Vitamin Reminder Web Application
2. Informed Consent Goes Mobile Helping Patients and Clinicians Cut Confusion and Paperwork
3. Subaru Donates Hep B Hero Mobile to Support Campaign
4. Toms of Maine and charity: water Team Up to Fund Global Clean Water Projects With Instant, Mobile Donation Campaign
5. Quepasa to Launch New Micro Blog and Mobile Initiatives With Dr. Rey
6. Glide Health Corporation and Integrated Medical Professionals Announce Partnership to Deploy the Glide Mobile Health Platform to Over One Million Patients and Over 100 Physicians in 50 Locations
7. VisionSync Launches a Smart iPhone First Aid App, iMobile Care
8. MedShare and Qualicode Bring BlackBerry Mobile EMR to Quebec
9. Blood diagnosis -- chip-based and mobile
10. InfoLogix to Present Mobile in the Enterprise: Keeping up with User Demand While Containing Costs at Mobile Monday Panel in Philadelphia
11. New Mobile STAR Cranial Center of Excellence Vehicle Brings Cutting-Edge Treatment to Satellite Communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... SyncDog, Inc., the leading ... magazine, a leading online tech news platform connecting technology innovators with news, experience, ... explores the state of enterprise mobility security today, and how the SyncDog SentinelSecure™ ...
(Date:12/5/2016)... ... 05, 2016 , ... Worldwise ®, a leading consumer ... kathy ireland® Worldwide for five additional years, announced by Kevin Fick, Worldwise CEO. ... agreement three years ago to design and develop the kathy ireland® Loved Ones™ ...
(Date:12/5/2016)... ... December 05, 2016 , ... Physicians Education Resource®, ... International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, on February ... are honored to have Amy E. Herman present at this year’s conference, her ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology: